Breast Cancer Research and Treatment
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 3.3 | Q2 | 52.9% | 1.340 | Q1 | 90.2% |
| 2024 | 3.0 | Q2 | 56.1% | 1.351 | Q1 | 90.6% |
| 2023 | 3.0 | Q2 | 52.4% | 1.267 | Q1 | 90.2% |
| 2022 | 3.8 | Q2 | 57.0% | 1.442 | Q1 | 92.6% |
| 2021 | 4.6 | Q3 | 61.3% | 1.407 | Q1 | 92.3% |
| 2020 | — | — | 1.908 | Q1 | 95.2% | |
| 2019 | — | — | 1.905 | Q1 | 95.3% | |
| 2018 | — | — | 1.899 | Q1 | 94.5% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1573-7217
ISSN
0167-6806
country
UScoverage
1981-2026